YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
65 hedge funds and large institutions have $342M invested in Y-mAbs Therapeutics in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.34% more ownership
Funds ownership: 32.09% → 38.43% (+6.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
65
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$22.3M | |
| 2 | +$10.7M | |
| 3 | +$6.6M | |
| 4 |
BlackRock
New York
|
+$4.45M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.47M |
Top Sellers
| 1 | -$5.67M | |
| 2 | -$3.03M | |
| 3 | -$686K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$256K |
| 5 |
Citigroup
New York
|
-$138K |